HBV
Chronic HBV infection can lead to advanced liver disease, including cirrhosis and hepatocellular carcinoma. Hepatitis B is viewed as a specific immunity-mediated liver disease. Control of covalently closed circular DNA (cccDNA) amplification is an important feature necessary for the ability of hepadnaviruses to persistently infect cells, without cytopathic effects. The high level of viral replication and cccDNA copy number induce cytopathic changes in both cell culture and the livers of infected animals. HBV replication may also disturb intracellular organelles, causing ER stress and alteration of mitochondrial function and increased replication may lead to depletion of cellular molecular resources like phospholipids that are needed for synthesis of cellular membrane, lipoproteins, and HBV sub and full viral particles. Liver injury can be caused not only by high levels of viral replication in infected hepatocytes, but also by the accumulation of the viral proteins in the absence of HBV replication in hepatocytes. Accumulation of viral proteins does occur in livers of patients with chronic HBV infection.
References
1.Zhang YY and Hu KQ. J Med Virol. 2015;87(12):1989–1999.
References
1.Zhang YY and Hu KQ. J Med Virol. 2015;87(12):1989–1999.
Microbiology/Virology
HBV
-
HBV-IN-37
产品货号 : M37076
cas no: 380483-01-2
HBV-IN-37 是一种 HBV 抑制剂,EC50 值为 10 μM。 -
Burfiralimab
产品货号 : M36776
cas no: 2460809-80-5
Burfiralimab (hzVSF-v13) 是一种针对病毒感染细胞表面表达的波形蛋白的单克隆 IgG4 抗体,具有广谱抗病毒活性和对病毒引起的炎症的抗炎作用。Burfiralimab可用于重症 COVID-19 研究。 -
ccc_R08
产品货号 : M36524
cas no: 2919019-72-8
ccc_R08 是一种无细胞毒性且口服有效的 cccDNA 抑制剂,可降低 HBV 感染小鼠肝脏中的 cccDNA 水平。ccc_R08 可用于 HBV病毒 (乙型肝炎病毒) 感染的研究。 -
Antiviral agent
产品货号 : M36065
cas no: 380458-45-7
Antiviral agent is thiazolidin-4-one with anti-hepatitis B activity -
Linvencorvir
产品货号 : M35768
cas no: 1808248-05-6
Linvencorvir 具有抗病毒活性.